TISSUEGNOSTICS GMBH

Their core work

TissueGnostics is a Vienna-based SME specializing in digital pathology and automated tissue image analysis. They provide software and technology platforms for quantitative analysis of tissue samples, supporting biomedical research in areas ranging from cancer biology to cell motility. Within EU projects, they contribute their tissue analysis expertise to large research training networks (MSCA), helping train early-stage researchers while advancing their own tools in clinical and translational contexts. Their most recent work extends into health data linkage, connecting pathology data with broader clinical datasets.

What they specialise in

How they've shifted over time

In the early period (2015-2018), TissueGnostics contributed to fundamental biomedical research — cell motility, cancer biology, and receptor-based therapeutics — where their tissue analysis tools supported laboratory-level science. By 2019, their focus shifted toward health data linkage (HELICAL), suggesting a move from pure image analysis toward integrating pathology data with clinical health records. This evolution points to a company broadening from a niche microscopy tool provider toward a more data-driven, clinically connected platform.

TissueGnostics appears to be moving from standalone tissue analysis toward clinical data integration, which could make them a valuable partner for projects combining pathology with real-world health data.

How they like to work

TissueGnostics exclusively joins projects as a partner or participant — never as coordinator — indicating they serve as a specialist technology provider rather than a project leader. They participate in large MSCA training networks with sizable consortia (88 unique partners across 16 countries), suggesting comfort operating within big, multi-institutional frameworks. Their role is best understood as a technology contributor embedded in research-driven consortia, offering their tools and expertise to support broader scientific objectives.

With 88 unique consortium partners across 16 countries, TissueGnostics has built a broad European network primarily through large MSCA training networks. Their partnerships span academic institutions and research organizations across the EU, though without a strong geographic concentration.

What sets them apart

TissueGnostics occupies a specific niche as an SME providing automated tissue analysis technology to large academic research consortia. Unlike many biotech SMEs that lead their own projects, they consistently serve as a technology enabler — bringing commercial-grade image analysis tools into research training environments. Their recent move into health data linkage suggests they can bridge the gap between laboratory pathology and clinical data systems, a combination not commonly found in small companies.

Highlights from their portfolio

• HELICAL
  Their most recent and best-funded project (EUR 264,207), marking a strategic pivot toward health data linkage and clinical data integration.
• ALKATRAS
  Participation in a translational cancer research network demonstrates their tissue analysis tools applied directly to oncology — a high-impact application area.